<MedlineCitation Status="Completed">
<MedlineID>10011398</MedlineID>
<PMID>420832</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-3002</ISSN>
<JournalIssue>
<Volume>551</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1979</Year>
<Month>Mar</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>A 13C NMR method for determination of the transbilayer distribution of phosphatidylcholine in large, unilamellar, protein-free and protein-containing vesicles.</ArticleTitle>
<Pagination>
<MedlinePgn>248-59</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>(1) Large unilamellar vesicles have been prepared from N-[Ne3-13C]-18 : 1c/18 : 1c-phosphatidylcholine, both with and without the major intrinsic proteins from the human erythrocyte membrane incorporated in the bilayer. (2) It is shown that the inside-outside distribution of the lipid molecules in these large unilamellar structures can be determined using 13C NMR. (3) Large vesicles of 18 : 1c/18 : 1c-phosphatidylcholine containing glycophorin show an enhanced permeability to Dy3+. It is shown that the permeability barrier of these vesicles can be restored by addition of 10 mol% 18 : 1c/18 : 1c-phosphatidylethanolamine or 1-18 : 1c-lysophosphatidylcholine.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Gerritsen</LastName>
<ForeName>W J</ForeName>
<Initials>WJ</Initials>
</Author>
<Author>
<LastName>van Zoelen</LastName>
<ForeName>E J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author>
<LastName>Verkleij</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author>
<LastName>de Kruijff</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author>
<LastName>van Deenen</LastName>
<ForeName>L L</ForeName>
<Initials>LL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Biochim Biophys Acta</MedlineTA>
<NlmUniqueID>0217513</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Glycophorin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phosphatidylcholines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Erythrocyte Membrane</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Freeze Fracturing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Glycophorin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Membranes, Artificial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Molecular Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Phosphatidylcholines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Protein Conformation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
